CAPRICOR THERAPEUTICS, INC.
For the period ended Dec 31, 2025. Filed Mar 17, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 17, 2026
CAPR$8.87-9.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Comprehensive Loss
FOR THE YEARS ENDED DECEMBER 31, 2025 AND 2024
| | | | | | | |
|---|---|---|---|---|---|---|
| · · Years ended December 31, | ||||||
| · · 2025 · · 2024 | ||||||
| | | | | | | |
| REVENUE | | | | | | |
| Revenue | | $— | | $22,270,465 | ||
| | | | | | | |
| TOTAL REVENUE | | — | | 22,270,465 | ||
| | | | | | | |
| OPERATING EXPENSES | | | | | ||
| Research and development | | 84,454,595 | | 49,968,585 | ||
| General and administrative | | 23,687,535 | | 14,865,122 | ||
| | | | | | | |
| TOTAL OPERATING EXPENSES | | 108,142,130 | | 64,833,707 | ||
| | | | | | | |
| LOSS FROM OPERATIONS | | (108,142,130) | | (42,563,242) | ||
| | | | | | | |
| OTHER INCOME (EXPENSE) | | | | | ||
| Other income | | 45,421 | | 7,471 | ||
| Investment income | | | 6,257,607 | | | 2,202,990 |
| Interest expense | | | (3,045,725) | | | — |
| Loss on disposal of fixed assets | | | (157,519) | | | (112,805) |
| | | | | | | |
| TOTAL OTHER INCOME (EXPENSE) | | 3,099,784 | | 2,097,656 | ||
| | | | | | | |
| LOSS BEFORE INCOME TAXES | | | (105,042,346) | | | (40,465,586) |
| (Provision for) benefit from income taxes | | | (1,600) | | | (1,600) |
| | | | | | | |
| NET LOSS | | $(105,043,946) | | $(40,467,186) | ||
| | | | | | | |
| OTHER COMPREHENSIVE INCOME (LOSS) | | | | | ||
| Net unrealized gain (loss) on marketable securities | | (743,801) | | 791,142 | ||
| | | | | | | |
| COMPREHENSIVE LOSS | | $(105,787,747) | | $(39,676,044) | ||
| | | | | | | |
| Net loss per share, basic and diluted | | $(2.26) | | $(1.15) | ||
| Weighted average number of shares, basic and diluted | | | 46,478,416 | | | 35,218,628 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.